content/01.abstract.md:5:bradykinesia
content/01.abstract.md:5:exosomes
content/01.abstract.md:5:exosomes
content/01.abstract.md:5:intracellular
content/01.abstract.md:5:LBD
content/01.abstract.md:5:LBD
content/01.abstract.md:5:Lewy
content/01.abstract.md:5:misfolded
content/01.abstract.md:5:misfolded
content/01.abstract.md:5:MSA
content/01.abstract.md:5:MSA
content/01.abstract.md:5:parkinsonian
content/01.abstract.md:5:pathologies
content/01.abstract.md:5:PSP
content/01.abstract.md:5:PSP
content/01.abstract.md:5:Supranuclear
content/01.abstract.md:5:synuclein
content/02.body-document.md:3:Charcot
content/02.body-document.md:3:Charcot
content/02.body-document.md:3:Dejerine
content/02.body-document.md:3:Friedrich
content/02.body-document.md:3:intraneuronal
content/02.body-document.md:3:Lewy
content/02.body-document.md:3:Lewy
content/02.body-document.md:3:Maladie
content/02.body-document.md:3:misfolded
content/02.body-document.md:3:MSA
content/02.body-document.md:3:MSA
content/02.body-document.md:3:nigra
content/02.body-document.md:3:substantia
content/02.body-document.md:3:synuclein
content/02.body-document.md:5:Arvid
content/02.body-document.md:5:carbidopa
content/02.body-document.md:5:Carlsson
content/02.body-document.md:5:dopaminergic
content/02.body-document.md:5:levodopa
content/02.body-document.md:5:Lewy
content/02.body-document.md:5:misfolded
content/02.body-document.md:5:MPTP
content/02.body-document.md:5:MSA
content/02.body-document.md:5:SNCA
content/02.body-document.md:5:synuclein
content/02.body-document.md:5:synuclein
content/02.body-document.md:7:Braak
content/02.body-document.md:7:dysregulation
content/02.body-document.md:7:Filip
content/02.body-document.md:7:Heiko
content/02.body-document.md:7:hypotension
content/02.body-document.md:7:microbiota
content/02.body-document.md:7:misfolded
content/02.body-document.md:7:misfolding
content/02.body-document.md:7:MSA
content/02.body-document.md:7:MSA
content/02.body-document.md:7:neurodegeneration
content/02.body-document.md:7:orthostatic
content/02.body-document.md:7:prodromal
content/02.body-document.md:7:reframed
content/02.body-document.md:7:Scheperjans
content/02.body-document.md:7:synuclein
content/02.body-document.md:7:synuclein
content/02.body-document.md:7:synuclein
content/02.body-document.md:11:Braak
content/02.body-document.md:11:Braak’s
content/02.body-document.md:11:Lewy
content/02.body-document.md:11:Lewy’s
content/02.body-document.md:11:microbiome
content/02.body-document.md:11:MSA
content/02.body-document.md:11:MSA
content/02.body-document.md:11:prodromal
content/02.body-document.md:11:synuclein
content/02.body-document.md:13:Pathogenesis
content/02.body-document.md:15:Braak
content/02.body-document.md:15:Braak
content/02.body-document.md:15:Braak’s
content/02.body-document.md:15:Braak’s
content/02.body-document.md:15:glia
content/02.body-document.md:15:microbiota
content/02.body-document.md:15:Misfolded
content/02.body-document.md:15:misfolding
content/02.body-document.md:15:MSA
content/02.body-document.md:15:mucosa
content/02.body-document.md:15:reframed
content/02.body-document.md:15:synuclein
content/02.body-document.md:17:Microbiome
content/02.body-document.md:19:dendritic
content/02.body-document.md:19:dipeptide
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:dysbiosis
content/02.body-document.md:19:glial
content/02.body-document.md:19:immunogenic
content/02.body-document.md:19:intracellular
content/02.body-document.md:19:lipopolysaccharide
content/02.body-document.md:19:LPS
content/02.body-document.md:19:LPS
content/02.body-document.md:19:MDP
content/02.body-document.md:19:MSA
content/02.body-document.md:19:MSA
content/02.body-document.md:19:muramyl
content/02.body-document.md:19:neurodegenerative
content/02.body-document.md:19:Oligomerization
content/02.body-document.md:19:overrepresentation
content/02.body-document.md:19:peptidoglycans
content/02.body-document.md:19:peptidoglycans
content/02.body-document.md:19:PGNs
content/02.body-document.md:19:PGNs
content/02.body-document.md:19:stimulator
content/02.body-document.md:21:DYSBIOSIS
content/02.body-document.md:21:MSA
content/02.body-document.md:23:cytosol
content/02.body-document.md:23:dipeptide
content/02.body-document.md:23:dysbiosis
content/02.body-document.md:23:endocytosed
content/02.body-document.md:23:EVs
content/02.body-document.md:23:EVs
content/02.body-document.md:23:immunogenic
content/02.body-document.md:23:LPS
content/02.body-document.md:23:MDP
content/02.body-document.md:23:muramyl
content/02.body-document.md:23:pathogenesis
content/02.body-document.md:23:peptidoglycan
content/02.body-document.md:25:dendritic
content/02.body-document.md:25:EVs
content/02.body-document.md:25:glial
content/02.body-document.md:25:intracellularly
content/02.body-document.md:25:LPS
content/02.body-document.md:25:LPS
content/02.body-document.md:25:MDP
content/02.body-document.md:25:microbiome
content/02.body-document.md:25:microbiota
content/02.body-document.md:25:peptidoglycans
content/02.body-document.md:25:propria
content/02.body-document.md:25:propria
content/02.body-document.md:27:axonal
content/02.body-document.md:27:dopaminergic
content/02.body-document.md:27:dopaminergic
content/02.body-document.md:27:dopaminergic
content/02.body-document.md:27:glial
content/02.body-document.md:27:pathogenesis
content/02.body-document.md:27:propria
content/02.body-document.md:27:submucosal
content/02.body-document.md:27:synuclein
content/02.body-document.md:27:synucleinopathies
content/02.body-document.md:27:unmyelinated
content/02.body-document.md:27:unmyelination
content/02.body-document.md:29:dopaminergic
content/02.body-document.md:29:dysbiosis
content/02.body-document.md:29:EGCs
content/02.body-document.md:29:EGCs
content/02.body-document.md:29:glia
content/02.body-document.md:29:glial
content/02.body-document.md:29:glial
content/02.body-document.md:29:LPS
content/02.body-document.md:29:MSA
content/02.body-document.md:29:multifunctional
content/02.body-document.md:29:neuroimmune
content/02.body-document.md:31:acetylcholine
content/02.body-document.md:31:cytokine
content/02.body-document.md:31:dysbiosis
content/02.body-document.md:31:glia
content/02.body-document.md:31:glial
content/02.body-document.md:31:modulatory
content/02.body-document.md:31:mucosal
content/02.body-document.md:31:neurotransmission
content/02.body-document.md:31:nicotinic
content/02.body-document.md:31:purinergic
content/02.body-document.md:33:dysregulate
content/02.body-document.md:33:glial
content/02.body-document.md:33:kynurenine
content/02.body-document.md:33:kynurenine
content/02.body-document.md:33:misfolding
content/02.body-document.md:33:MSA
content/02.body-document.md:33:neuroactive
content/02.body-document.md:33:synuclein
content/02.body-document.md:37:butyrate
content/02.body-document.md:37:Butyrate
content/02.body-document.md:37:cytokine
content/02.body-document.md:37:dysbiosis
content/02.body-document.md:37:LPS
content/02.body-document.md:37:microbiota
content/02.body-document.md:37:microbiota
content/02.body-document.md:37:MSA
content/02.body-document.md:37:overactivation
content/02.body-document.md:37:PGNs
content/02.body-document.md:37:propionate
content/02.body-document.md:37:SCFA
content/02.body-document.md:37:SCFAs
content/02.body-document.md:37:SCFAs
content/02.body-document.md:37:Tregs
content/02.body-document.md:39:biome
content/02.body-document.md:39:dysbiosis
content/02.body-document.md:39:dysbiosis
content/02.body-document.md:39:microbiome
content/02.body-document.md:39:microbiome
content/02.body-document.md:39:microbiome
content/02.body-document.md:39:microbiome
content/02.body-document.md:39:neurodegenerative
content/02.body-document.md:39:overrepresentation
content/02.body-document.md:39:SCFA
content/02.body-document.md:41:cytokine
content/02.body-document.md:41:kynurenine
content/02.body-document.md:41:MSA
content/02.body-document.md:41:MSA
content/02.body-document.md:41:neurodegeneration
content/02.body-document.md:41:neurodegenerative
content/02.body-document.md:41:neuroplasticity
content/02.body-document.md:41:neuroplasticity
content/02.body-document.md:41:neurotoxic
content/02.body-document.md:41:potentiators
content/02.body-document.md:41:prodromal
content/02.body-document.md:43:NEURODEGENERATION
content/02.body-document.md:43:NEUROPLASTICITY
content/02.body-document.md:47:dopaminergic
content/02.body-document.md:47:MSA
content/02.body-document.md:47:MSA
content/02.body-document.md:47:neurodegenerative
content/02.body-document.md:47:pathogenesis
content/02.body-document.md:47:PNS
content/02.body-document.md:47:PNS
content/02.body-document.md:47:synuclein
content/02.body-document.md:47:synucleinopathies
content/02.body-document.md:49:MSA
content/02.body-document.md:49:synucleinopathies
content/02.body-document.md:56:exosomes
content/02.body-document.md:56:MSA
content/02.body-document.md:56:synuclein
content/02.body-document.md:56:tRFs
content/02.body-document.md:58:exosomes
content/02.body-document.md:58:exosomes
content/02.body-document.md:58:Exosomes
content/02.body-document.md:58:Exosomes
content/02.body-document.md:58:MSA
content/02.body-document.md:58:neurodegenerative
content/02.body-document.md:58:oligodendrocytes
content/02.body-document.md:58:RNAs
content/02.body-document.md:58:synucleinopathies
content/02.body-document.md:60:oligomeric
content/02.body-document.md:60:synuclein
content/02.body-document.md:60:synucleinopathies
content/02.body-document.md:60:translationally
content/02.body-document.md:62:mucosa
content/02.body-document.md:62:proinflammatory
content/02.body-document.md:62:tRFs
content/02.body-document.md:62:tRFs
content/02.body-document.md:62:tRNAs
content/02.body-document.md:64:exosome
content/02.body-document.md:64:pathogenesis
content/02.body-document.md:64:synuclein
content/02.body-document.md:64:tRFs
content/02.body-document.md:66:Exosomes
content/02.body-document.md:68:biogenesis
content/02.body-document.md:68:endosomal
content/02.body-document.md:68:EVs
content/02.body-document.md:68:exocytosis
content/02.body-document.md:68:exosomes
content/02.body-document.md:68:Exosomes
content/02.body-document.md:68:intracellular
content/02.body-document.md:68:intraluminal
content/02.body-document.md:68:microvesicles
content/02.body-document.md:68:microvesicles
content/02.body-document.md:68:MSA
content/02.body-document.md:68:multivesicular
content/02.body-document.md:68:MVBs
content/02.body-document.md:68:RNAs
content/02.body-document.md:68:subtype
content/02.body-document.md:70:exosomes
content/02.body-document.md:70:prodromal
content/02.body-document.md:70:synucleinopathies
content/02.body-document.md:72:exosomes
content/02.body-document.md:72:exosomes
content/02.body-document.md:72:exosomes
content/02.body-document.md:72:misfolded
content/02.body-document.md:72:neurodegenerative
content/02.body-document.md:72:oligomeric
content/02.body-document.md:72:synuclein
content/02.body-document.md:74:Exosome
content/02.body-document.md:76:exosomes
content/02.body-document.md:78:centrifugation
content/02.body-document.md:80:centrifugation
content/02.body-document.md:80:exosomes
content/02.body-document.md:80:ultracentrifugation
content/02.body-document.md:81:Exosomes
content/02.body-document.md:81:Immunoaffinity
content/02.body-document.md:82:dopaminergic
content/02.body-document.md:82:exosomes
content/02.body-document.md:82:NCAM
content/02.body-document.md:83:CNPase
content/02.body-document.md:83:exosomes
content/02.body-document.md:83:MOG
content/02.body-document.md:83:oligodendrocyte
content/02.body-document.md:84:exosomes
content/02.body-document.md:84:lysed
content/02.body-document.md:84:Lysis
content/02.body-document.md:84:miRNAs
content/02.body-document.md:84:tRFs
content/02.body-document.md:86:exosome
content/02.body-document.md:86:immunoprecipitation
content/02.body-document.md:86:POC
content/02.body-document.md:86:ultracentrifuges
content/02.body-document.md:90:exosome
content/02.body-document.md:90:exosome
content/02.body-document.md:90:microfluidics
content/02.body-document.md:94:Translational
content/02.body-document.md:96:levodopa
content/02.body-document.md:96:MSA
content/02.body-document.md:96:MSA
content/02.body-document.md:96:MSA
content/02.body-document.md:98:axonal
content/02.body-document.md:98:demyelination
content/02.body-document.md:98:glial
content/02.body-document.md:98:MSA
content/02.body-document.md:98:MSA
content/02.body-document.md:98:oligodendrocyte
content/02.body-document.md:98:pathologies
content/02.body-document.md:98:preclinical
content/02.body-document.md:98:remyelination
content/02.body-document.md:98:repurposing
content/02.body-document.md:100:demyelinating
content/02.body-document.md:100:MSA
content/02.body-document.md:100:MSA
content/02.body-document.md:100:myeloma
content/02.body-document.md:147:adipiscing
content/02.body-document.md:147:aliqua
content/02.body-document.md:147:amet
content/02.body-document.md:147:consectetur
content/02.body-document.md:147:dolore
content/02.body-document.md:147:eiusmod
content/02.body-document.md:147:elit
content/02.body-document.md:147:incididunt
content/02.body-document.md:147:ipsum
content/02.body-document.md:147:labore
content/02.body-document.md:147:Lorem
content/02.body-document.md:147:magna
content/02.body-document.md:147:sed
content/02.body-document.md:147:tempor
content/02.body-document.md:148:aliquip
content/02.body-document.md:148:commodo
content/02.body-document.md:148:consequat
content/02.body-document.md:148:enim
content/02.body-document.md:148:exercitation
content/02.body-document.md:148:laboris
content/02.body-document.md:148:nisi
content/02.body-document.md:148:nostrud
content/02.body-document.md:148:quis
content/02.body-document.md:148:ullamco
content/02.body-document.md:148:veniam
content/02.body-document.md:149:aute
content/02.body-document.md:149:cillum
content/02.body-document.md:149:dolore
content/02.body-document.md:149:Duis
content/02.body-document.md:149:esse
content/02.body-document.md:149:fugiat
content/02.body-document.md:149:irure
content/02.body-document.md:149:pariatur
content/02.body-document.md:149:reprehenderit
content/02.body-document.md:149:velit
content/02.body-document.md:149:voluptate
content/02.body-document.md:150:anim
content/02.body-document.md:150:culpa
content/02.body-document.md:150:cupidatat
content/02.body-document.md:150:deserunt
content/02.body-document.md:150:Excepteur
content/02.body-document.md:150:laborum
content/02.body-document.md:150:mollit
content/02.body-document.md:150:occaecat
content/02.body-document.md:150:officia
content/02.body-document.md:150:proident
content/02.body-document.md:150:qui
content/02.body-document.md:150:sint
content/02.body-document.md:150:sunt
content/02.body-document.md:340:Pandoc's
content/02.body-document.md:350:Pandoc's
